Cargando…
Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial
Statins have anti-inflammatory and immunomodulatory properties in addition to lipid-lowering effects. The present study evaluated the effect of atorvastatin added to interferon beta-1b in multiple sclerosis (MS) in a multicenter, randomized, parallel-group, rater-blinded study performed in eight Swi...
Autores principales: | Kamm, Christian Philipp, El-Koussy, Marwan, Humpert, Sebastian, Findling, Oliver, von Bredow, Ferdinand, Burren, Yuliya, Schwegler, Guido, Schött, Dagmar, Donati, Filippo, Müller, Martin, Goebels, Norbert, Müller, Felix, Slotboom, Johannes, Tettenborn, Barbara, Kappos, Ludwig, Naegelin, Yvonne, Mattle, Heinrich Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484273/ https://www.ncbi.nlm.nih.gov/pubmed/22569835 http://dx.doi.org/10.1007/s00415-012-6513-7 |
Ejemplares similares
-
Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial
por: Kamm, Christian P., et al.
Publicado: (2014) -
SWiss Atorvastatin and Interferon Beta-1b Trial In Multiple Sclerosis (SWABIMS) - rationale, design and methodology
por: Kamm, Christian P, et al.
Publicado: (2009) -
Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis—A Cohort Study
por: Findling, Oliver, et al.
Publicado: (2015) -
Practice Effects of Mobile Tests of Cognition, Dexterity, and Mobility on Patients With Multiple Sclerosis: Data Analysis of a Smartphone-Based Observational Study
por: Woelfle, Tim, et al.
Publicado: (2021) -
Measuring and Validating the Levels of Brain-Derived Neurotrophic Factor in Human Serum
por: Naegelin, Yvonne, et al.
Publicado: (2018)